Aripiprazole: A third generation of antipsychotics begins?

Perspectives in Psychiatric Care

Volumn 38, Issue 4, 2002, Pages 157-159

  Keltner, Norman L ^a   Johnson, Vicki ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antipsychotics; Aripiprazole

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUPHENAZINE; HALOPERIDOL; NEUROTRANSMITTER; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; ZIPRASIDONE;

ARTICLE; HUMAN; SCHIZOPHRENIA; COGNITION; DRUG ANTAGONISM; EXTRAPYRAMIDAL SYMPTOM; FOOD AND DRUG ADMINISTRATION; LIMBIC CORTEX; NEGATIVE FEEDBACK; NIGRONEOSTRIATAL SYSTEM; PRESYNAPTIC NERVE; PROLACTIN BLOOD LEVEL; SEDATION; SHORT SURVEY; SYMPTOM; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; HUMANS; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA;

EID: 0036825218     PISSN: 00315990     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2002.tb01566.x     Document Type: Article

References (7)

1. Burris, K.D., Molski, T.F., Ryan, E., Tottori, K., Kikuchi, T., Yocca, F.D., & Molinoff, P.B. (2002). Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. Journal of Pharmacology and Experimental Therapeutics, 302, 381-389.
2. Jordan, S., Koprivica, V., Chen, R., Tottori, K., Kikuchi, T., & Altar, C.A. (2002). The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. European Journal of Pharmacology, 441, 137-140.
3. Kane, J.M., Carson, W.H., Saha, A.R., McQuade, R.D., Ingenito, G.G., Zimbroff, D.L., & Ali, M.W. (2002). Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. Journal of Clinical Psychiatry, 63, 763-771.
4. Stahl, S.M. (2001a). Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, Part I: 'Goldilocks' actions at dopamine receptors. Journal of Clinical Psychiatry, 62, 841-842.
5. Stahl, S.M. (2001b). Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, Part II: Illustrating their mechanism of action. Journal of Clinical Psychiatry, 62, 923-924.
6. Tamminga, C.A. (2002). Partial dopamine agonists in the treatment of psychosis. Journal of Neural Transmission, 109, 411-420.
7. Yokoi, F., Grunder, G., Biziere, K., Stephane, M., Dogan, A.S., Dannals, R.F., et al. (2002). Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): A study using positron emission tomography and [11-C]raclopride. Neuropsychopharmacology, 27, 248-259.